Loading...
11 Oman Device Drug Combination Reports
Country Covered: Oman
Study Period: 2019 - 2029
Major Players: Abbott Diabetes Care, Novo Nordisk A/S, Medtronic PLC, Eli Lilly and Company, Roche Diabetes Care
Country Covered: Oman
Study Period: 2019 - 2029
Major Players: Medtronics, Roche, NovoNordisk, Sanofi, Omnipod
Country Covered: Oman
Study Period: 2017 - 2028
Major Players: Novo Nordisk, Julphar, Novartis, Becton and Dickinson, Terumo
Country Covered: Oman
Study Period: 2018 - 2029
Major Players: Abbott Diabetes Care, Medtronic PLC, Roche Diabetes Care, Dexcom Inc., Novo Nordisk A/S
Country Covered: Oman
Study Period: 2018 - 2029
Major Players: Becton and Dickinson, Medtronic PLC, Novo Nordisk A/S, Sanofi Aventis, Eli Lilly and Company
Country Covered: Oman
Study Period: 2018 - 2029
Major Players: Novo Nordisk A/S, Julphar, Biocon, Sanofi, Eli Lilly and Company
Country Covered: Oman
Study Period: 2019 - 2029
Major Players: Novo Nordisk A/S, Medtronic, Dexcom Inc., Abbott Diabetes Care, Roche Diabetes Care
Country Covered: Oman
Study Period: 2018 - 2029
Major Players: Novo Nordisk, Sanofi, El lilly, Medtronics, Roche
Country Covered: Oman
Study Period: 2018-2029
Major Players: Abbott, Medtronic, Lilly, Novo Nordisk, Roche
Country Covered: Oman
Study Period: 2019 - 2029
Major Players: Novo Nordisk, Medtronic, Sanofi, Ypsomed, Eli Lilly and Company
Country Covered: Oman
Study Period: 2018 - 2029
Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Julphar